Editorial
Open access
Aug 2026
Could chimeric antigen receptor-T cell treatment of atherosclerosis in mice translate to a human therapy?
The genetic engineering of chimeric antigen receptor T (CAR-T) cells provides a means of generating large numbers of T cells specific for a single antigen, and these cells have attracted increasing interest as a treatment in diseases associated with inflammation.
S. Gieseg, B. Hock, M. Ogugofor et al.
· Annals of Translational Medi... · 0 citations